Posted on September 19, 20239/19/23
New Models of Benefits Verification Solve for Complexity, Accelerate Speed to Therapy and Deliver Price Transparency
Posted on September 6, 20239/6/23
Unlocking Your Full North American Potential: Coordinating Launches in The U.S. and Canada
Posted on July 13, 20237/13/23
Position Your Future-Facing Strategy on Digital Therapeutics (DTx) in China
Posted on July 5, 20237/5/23
Health Disparity Solutions Build Healthier Communities and a More Equitable Medical Landscape
Posted on June 20, 20236/20/23
Key Considerations When Operationalizing Revenue Management
Posted on June 16, 20236/16/23
Understanding the Inflation Reduction Act: Drug Price Negotiation
Posted on June 16, 20236/16/23
Digital Guide to Commercializing Complex Therapeutics
Posted on June 12, 20236/12/23
Informing Optimal Pricing Strategies with a Comprehensive Modeling Approach
Posted on May 25, 20235/25/23
The Influx of Generic Launches Leaves Narrow Opportunities for Multiple Sclerosis Access
Posted on May 17, 20235/17/23